Relationship between plasma mid-regional pro-adrenomedullin level and resistance to antihypertensive therapy in stable kidney transplant recipients

[1]  D. Hu,et al.  Factors Associated with Blood Pressure Control in Hypertensive Patients with Coronary Heart Disease: Evidence from the Chinese Cholesterol Education Program , 2013, PloS one.

[2]  Fumihiko Katagiri,et al.  Significant decrease in plasma midregional proadrenomedullin level in patients with end-stage renal disease after living kidney transplantation , 2013, Peptides.

[3]  Fumihiko Katagiri,et al.  Development and clinical application of an enzyme immunoassay for the determination of midregional proadrenomedullin , 2013, Journal of peptide science : an official publication of the European Peptide Society.

[4]  F. Kronenberg,et al.  The Association of Mid-Regional Pro-Adrenomedullin and Mid-Regional Pro-Atrial Natriuretic Peptide with Mortality in an Incident Dialysis Cohort , 2011, PloS one.

[5]  F. Kronenberg,et al.  Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study. , 2009, Kidney international.

[6]  K. Bailey,et al.  Novel Use of Kaplan–Meier Methods to Explain Age and Gender Differences in Hypertension Control Rates , 2008, Hypertension.

[7]  N. Morgenthaler,et al.  Midregional proadrenomedullin reflects cardiac dysfunction in haemodialysis patients with cardiovascular disease. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  T. Nishikimi.  Adrenomedullin in the kidney-renal physiological and pathophysiological roles. , 2007, Current medicinal chemistry.

[9]  K. Kitamura,et al.  Plasma adrenomedullin level and development of hypertension , 2006, Journal of Human Hypertension.

[10]  H. Zulewski,et al.  Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. , 2005, Endocrinology.

[11]  J. Struck,et al.  Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients , 2004, Peptides.

[12]  P. Zipfel,et al.  Complement Factor H Is a Serum-binding Protein for Adrenomedullin, and the Resulting Complex Modulates the Bioactivities of Both Partners* , 2001, The Journal of Biological Chemistry.

[13]  H. Esumi,et al.  Identification of Hypoxia-inducible Factor 1 Ancillary Sequence and Its Function in Vascular Endothelial Growth Factor Gene Induction by Hypoxia and Nitric Oxide* , 2001, The Journal of Biological Chemistry.

[14]  D. Smith,et al.  Adrenomedullin, a multifunctional regulatory peptide. , 2000, Endocrine reviews.

[15]  S. Bloom,et al.  Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. , 1997, The Journal of clinical endocrinology and metabolism.

[16]  Y. Koiwaya,et al.  Increased plasma adrenomedullin levels in chronic congestive heart failure. , 1996, American heart journal.

[17]  Y. Hirata,et al.  Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. , 1996, The Journal of clinical endocrinology and metabolism.

[18]  K. Kangawa,et al.  Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. , 1993, Biochemical and biophysical research communications.

[19]  T. Kitagawa,et al.  Preparation and Characterization of Hetero-bifunctional Cross-linking Reagents for Protein Modifications , 1981 .

[20]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .